What is the role of nitric oxide in murine and human host defense against tuberculosis?Current knowledge (Q34442443)

2 August 2017

1 reference

title

What is the role of nitric oxide in murine and human host defense against tuberculosis?Current knowledge (English)

1 reference

2 August 2017

0 references

Chan ED

1

1 reference

PubMed ID

11713103

2 August 2017

Chan J

series ordinal

2

1 reference

PubMed ID

11713103

2 August 2017

Schluger NW

series ordinal

3

1 reference

2 August 2017

1 November 2001

1 reference

American Journal of Respiratory Cell and Molecular Biology

2 August 2017

1 reference

2 August 2017

25

1 reference

2 August 2017

606-612

1 reference

2 August 2017

5

1 reference

Genetic, biochemical, and clinical features of chronic granulomatous disease.

2 August 2017

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

In-vitro synergy of paromomycin with metronidazole alone or metronidazole plus hydroxymetronidazole against Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Induction of apoptosis in murine macrophages by Mycobacterium tuberculosis is reactive oxygen intermediates-independent

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Peroxynitrite reductase activity of bacterial peroxiredoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Identification of nitric oxide synthase as a protective locus against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Rapid induction of mRNA for nitric oxide synthase II in rat alveolar macrophages by intratracheal administration of Mycobacterium tuberculosis and Mycobacterium avium

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Inhibition of virulent Mycobacterium tuberculosis by Bcg(r) and Bcg(s) macrophages correlates with nitric oxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Early inhibition of mycobacterial growth by human alveolar macrophages is not due to nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Mycobacterium tuberculosis (MTB)-stimulated production of nitric oxide by human alveolar macrophages and relationship of nitric oxide production to growth inhibition of MTB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Induction of nitric oxide in human monocytes and monocyte cell lines by Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Alveolar macrophages from C3H/HeJ mice show sensitivity to endotoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Expression of inducible nitric oxide synthase in human granulomas and histiocytic reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Expression of inducible nitric oxide in human lung epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Nitric oxide expression in airway epithelial cells in response to tubercle bacilli stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Surfactant protein A suppresses reactive nitrogen intermediates by alveolar macrophages in response to Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Mycobacterium tuberculosis-activated dendritic cells induce protective immunity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Thymic dendritic cells express inducible nitric oxide synthase and generate nitric oxide in response to self- and alloantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Fate of Mycobacterium tuberculosis within murine dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: A novel pathway of autocrine macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Activated T cells induce macrophages to produce NO and control Leishmania major in the absence of tumor necrosis factor receptor p55.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

The CD40/CD40 ligand interaction is required for resistance to toxoplasmic encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

CD40 ligand is not essential for induction of type 1 cytokine responses or protective immunity after primary or secondary infection with histoplasma capsulatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

CD40 ligand and its role in X-linked hyper-IgM syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Interferon gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Induction of inducible nitric oxide synthase-NO* by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-kappaB signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

A novel antioxidant gene from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Alkyl hydroperoxide reductase subunit C (AhpC) protects bacterial and human cells against reactive nitrogen intermediates

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Nitrate reduction as a marker for hypoxic shiftdown of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

An antimicrobial activity of cytolytic T cells mediated by granulysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

Granulysin, a T cell product, kills bacteria by altering membrane permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.5.4487

21 January 2018

Identifiers

DOI

10.1165/AJRCMB.25.5.4487

1 reference

2 August 2017

1 reference

PubMed ID

11713103